A new report has revealed an important achievement regarding the vaccination effect on cervical cancer cases in England. After the HPV (human papillomavirus) vaccine was given to children aged 12-13, the number of deaths from cervical cancer in young women has almost dropped to zero.
The HPV vaccine was introduced in Britain in 2008, with the aim of preventing the virus, one of the leading causes of cervical cancer. This virus can infect the body and cause abnormal changes in the cervical cells, which later develop into cancer.
A recent research review by the Health Department has found that among those who have got the vaccine at the age of 12 to 13 years, the death rate due to cervical cancer is close to zero. This is a direct proof of the effectiveness of the vaccine and clearly shows the success of the nationwide vaccination program.
According to experts, the main reason for this reduction is the strength of regular screening programs along with vaccination. Through screening, abnormal cells can be detected in the early stages and timely treatment can be done. Doctors and health experts have said that widespread access to the HPV vaccine among young women can significantly reduce the incidence of such cancers. The NHS (National Health Service) has also said that this achievement is a great hope for the coming generations and the government is committed to expanding this vaccination campaign in the future also. Researchers hope that in the coming years, this vaccine will lead to even greater progress in cervical cancer control around the world.
This study underscores the importance of vaccination and encourages parents, health workers, and policymakers to support such programs. By adopting HPV vaccine, not only individuals are protected, but prevention of this deadly disease becomes possible in the entire society.
